share_log

12 Health Care Stocks Moving In Monday's After-Market Session

Benzinga ·  May 14 04:31

Gainers

  • Aesthetic Medical Intl (NASDAQ:AIH) shares moved upwards by 23.3% to $0.57 during Monday's after-market session. The market value of their outstanding shares is at $27.0 million.
  • Harrow (NASDAQ:HROW) shares rose 13.5% to $13.7. The market value of their outstanding shares is at $484.7 million. As per the press release, Q1 earnings came out today.
  • Vaxart (NASDAQ:VXRT) stock moved upwards by 12.19% to $0.92. The market value of their outstanding shares is at $162.6 million. The company's, Q1 earnings came out today.
  • Modular Medical (NASDAQ:MODD) shares moved upwards by 7.77% to $1.94. The market value of their outstanding shares is at $60.1 million.
  • Gossamer Bio (NASDAQ:GOSS) stock moved upwards by 6.94% to $0.77. The market value of their outstanding shares is at $174.1 million. As per the press release, Q1 earnings came out 4 days ago.
  • Lantern Pharma (NASDAQ:LTRN) stock moved upwards by 6.43% to $6.48. The company's market cap stands at $69.7 million. As per the news, the Q1 earnings report came out 2 days ago.

Losers

  • Augmedix (NASDAQ:AUGX) shares fell 33.8% to $1.55 during Monday's after-market session. The company's market cap stands at $75.8 million. The company's, Q1 earnings came out today.
  • Akoya Biosciences (NASDAQ:AKYA) stock decreased by 19.91% to $3.3. The market value of their outstanding shares is at $162.9 million. As per the press release, Q1 earnings came out today.
  • Calidi Biotherapeutics (AMEX:CLDI) shares fell 5.0% to $0.21. The market value of their outstanding shares is at $10.3 million.
  • Elevation Oncology (NASDAQ:ELEV) stock declined by 4.81% to $3.37. The company's market cap stands at $184.1 million.
  • Rockwell Medical (NASDAQ:RMTI) stock decreased by 4.71% to $1.62. The company's market cap stands at $47.5 million.
  • Inotiv (NASDAQ:NOTV) stock declined by 4.08% to $4.0. The market value of their outstanding shares is at $103.1 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment